BriDGE-based Surgical Matrices

About Harbor MedTech

Harbor MedTech is a privately held, commercial-stage company developing regenerative medicine solutions for soft tissue repair. Its core asset is the BriDGE® technology, a proprietary collagen processing method that creates a matrix shown in studies to accelerate healing, support regeneration, and exhibit antimicrobial properties. The company currently has two FDA-cleared and CE-marked products and is advancing a pipeline targeting sports medicine, hernia/breast reconstruction, and chronic wounds. Harbor MedTech operates as a fully integrated entity, positioning itself to capture value in the growing orthopedic biologics and advanced wound care markets.

Therapeutic Areas